Putnam Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $10.1M | Sell |
31,394
-16,512
| -34% | -$5.18M | 0.01% | 324 |
|
|
2023
Q3 | $17.2M | Sell |
47,906
-1,618
| -3% | -$624K | 0.03% | 231 |
|
|
2023
Q2 | $18.8M | Sell |
49,524
-84,664
| -63% | -$34.5M | 0.03% | 217 |
|
|
2023
Q1 | $64.3M | Buy |
134,188
+9,204
| +7% | +$4.31M | 0.1% | 138 |
|
|
2022
Q4 | $52.6M | Buy |
124,984
+31,940
| +34% | +$12.9M | 0.09% | 142 |
|
|
2022
Q3 | $38.8M | Buy |
93,044
+48,237
| +108% | +$24M | 0.07% | 153 |
|
|
2022
Q2 | $22.2M | Buy |
44,807
+8,285
| +23% | +$4.31M | 0.04% | 199 |
|
|
2022
Q1 | $20.6M | Sell |
36,522
-35,673
| -49% | -$21.5M | 0.03% | 221 |
|
|
2021
Q4 | $54.5M | Sell |
72,195
-6,280
| -8% | -$4.7M | 0.08% | 155 |
|
|
2021
Q3 | $58.5M | Buy |
78,475
+296
| +0.4% | +$222K | 0.09% | 158 |
|
|
2021
Q2 | $50.4M | Buy |
78,179
+1,060
| +1% | +$645K | 0.08% | 167 |
|
|
2021
Q1 | $44M | Sell |
77,119
-18,806
| -20% | -$11.1M | 0.07% | 182 |
|
|
2020
Q4 | $55.9M | Sell |
95,925
-6,599
| -6% | -$3.76M | 0.1% | 160 |
|
|
2020
Q3 | $52.8M | Sell |
102,524
-8,915
| -8% | -$4.52M | 0.1% | 153 |
|
|
2020
Q2 | $50.3M | Buy |
111,439
+62,870
| +129% | +$27.7M | 0.11% | 149 |
|
|
2020
Q1 | $17M | Buy |
48,569
+32,990
| +212% | +$12.1M | 0.04% | 233 |
|
|
2019
Q4 | $5.76M | Buy |
15,579
+501
| +3% | +$177K | 0.01% | 480 |
|
|
2019
Q3 | $5.02M | Hold |
15,078
| – | – | 0.01% | 503 |
|
|
2019
Q2 | $4.71M | Buy |
15,078
+600
| +4% | +$180K | 0.01% | 531 |
|
|
2019
Q1 | $4.42M | Sell |
14,478
-115,353
| -89% | -$31.1M | 0.01% | 542 |
|
|
2018
Q4 | $30.1M | Sell |
129,831
-9,987
| -7% | -$2.68M | 0.08% | 195 |
|
|
2018
Q3 | $43.8M | Buy |
139,818
+9,447
| +7% | +$2.93M | 0.09% | 174 |
|
|
2018
Q2 | $37.6M | Sell |
130,371
-6,500
| -5% | -$1.79M | 0.09% | 195 |
|
|
2018
Q1 | $34.2M | Sell |
136,871
-108,114
| -44% | -$27.5M | 0.08% | 210 |
|
|
2017
Q4 | $58.5M | Buy |
244,985
+23,960
| +11% | +$5.81M | 0.13% | 159 |
|
|
2017
Q3 | $49.1M | Buy |
221,025
+8,934
| +4% | +$2.01M | 0.11% | 162 |
|
|
2017
Q2 | $48M | Buy |
212,091
+118,840
| +127% | +$25.9M | 0.11% | 166 |
|
|
2017
Q1 | $18.6M | Buy |
+93,251
| New | +$18M | 0.04% | 292 |
|
|
2016
Q3 | – | Sell |
-12,885
| Closed | -$1.84M | – | 1266 |
|
|
2016
Q2 | $1.84M | Buy |
12,885
+150
| +1% | +$21.4K | ﹤0.01% | 955 |
|
|
2016
Q1 | $1.74M | Sell |
12,735
-878
| -6% | -$115K | ﹤0.01% | 986 |
|
|
2015
Q4 | $1.89M | Buy |
13,613
+991
| +8% | +$137K | ﹤0.01% | 991 |
|
|
2015
Q3 | $1.7M | Buy |
+12,622
| New | +$1.82M | ﹤0.01% | 1033 |
|
Other funds holding BIO
VAM
Putnam Investments's BIO Position: Q4 2023 in Review
Putnam Investments reduced its Bio-Rad Laboratories Class A (BIO) stake by 34% in Q4 2023, selling an estimated $5.18M and leaving 31,394 shares worth $10.1M. The position accounts for 0.01% of the portfolio, ranked #324.
Putnam Investments first reported a position in BIO in Q3 2015 and has held it in 32 quarters since. The position peaked at $64.3M in Q1 2023. 483 funds tracked by Wall St. Rank hold BIO as of Q4 2023.
- Putnam Investments held 31,394 shares of Bio-Rad Laboratories Class A worth $10.1M as of Q4 2023.
- Putnam Investments sold 16,512 Bio-Rad Laboratories Class A shares in Q4 2023, an estimated $5.18M.
- Bio-Rad Laboratories Class A made up 0.01% of Putnam Investments's portfolio in Q4 2023, its #324 holding.
- Putnam Investments first reported a position in Bio-Rad Laboratories Class A in Q3 2015 and has held it in 32 quarters since.
- Putnam Investments's Bio-Rad Laboratories Class A position peaked at $64.3M in Q1 2023.
- 483 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2023.
Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.